Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists.
Hagan
R M
RM
Department of Neuropharmacology, Glaxo Group Research, Ware, UK.
Beresford
I J
IJ
Stables
J
J
Dupere
J
J
Stubbs
C M
CM
Elliott
P J
PJ
Sheldrick
R L
RL
Chollet
A
A
Kawashima
E
E
McElroy
A B
AB
D000375:Aging / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D000831:Animals, Newborn; D001345:Autoradiography; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D016466:CHO Cells; D006224:Cricetinae; D006801:Humans; D007082:Ileum / Q000378:metabolism; D007700:Kinetics; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000378:metabolism; D011869:Radioligand Assay; D051381:Rats; D018041:Receptors, Neurokinin-2 / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011994:Recombinant Proteins / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism; D015320:Tachykinins / Q000494:pharmacology; D014162:Transfection; D014316:Tritium
D009842:Oligopeptides; D018041:Receptors, Neurokinin-2; D011994:Recombinant Proteins; D015320:Tachykinins; D014316:Tritium; C083380:GR 100679